Poster Abstracts • OFID 2017:4 (Suppl 1) • S307 collected from medical records, and long-term outcomes were assessed by telephone interviews and quantified through modified Rankin scores (mRS).
Background. The incidence of meningitis, particularly bacterial meningitis, is decreasing due to widespread vaccine use with etiologies still due to relatively common organisms. However, risk factors for the development of meningitis are largely unknown. We describe the epidemiology of meningitis among the pediatric population of KPNC and assess the association between prior TBI and meningitis.
Methods. We conducted a retrospective descriptive study among KPNC pediatric patients (1 month-18 years) between July 2012 -June 2016 with an ICD-9 meningitis diagnosis. Charts were reviewed to a.) verify and classify the meningitis diagnosis and b.) ascertain prior TBI history. Cases were classified as confirmed, probable, or possible based on clinical course, CSF culture, PCR, and CSF profile. The proportion of meningitis cases with a history of TBI was compared with the published rate of TBI in the general pediatric population.
Results. Of 266 cases reviewed, 146 cases were verified as meningitis with 19 confirmed/probable bacterial [(S. pneumoniae (7), E. coli (3), S. Agalactiae (3), N. meningitidis (2), S. Aureus (1), and not otherwise specified (3)] and 50 confirmed/probable viral [(enterovirus (44) , HSV2 (4), HSV1 (1), and WNV (1)] etiologies. An additional 77 possible cases included primarily viral etiologies (65) and a minority of possible bacterial (6) or infection-related inflammatory (6) etiologies. 120 were excluded. The overall meningitis and confirmed bacterial meningitis estimated incidence rate was 17.9 per 100,000 and 2.7 per 100,000, respectively. Twenty meningitis cases (13.7%) had a history of TBI (all of which were concussions) compared with the concussion rate in the general pediatric population reported by AL Zhang et al of 0.7% (P < 0.001).
Conclusion. Our results are consistent with recent studies showing a decline in bacterial meningitis. Enteroviral meningitis remains the leading cause of identified etiologies. However, in a sizable proportion of cases there was no specific pathogen identified. An increased risk of developing meningitis may be associated with TBIs.
Disclosures. All authors: No reported disclosures. Friday, October 6, 2017: 12:30 PM Background. HSV encephalitis is a life-threatening disease process that requires prompt treatment. Diagnosis is often dependent upon nucleic acid studies of CNS samples. We introduced the Film Array Meningitis/Encephalitis (ME) Panel, a qualitative multiplexed nucleic acid-based diagnostic test for a variety of CNS pathogens, including HSV, in June 2016. It replaced an equivalent reference laboratory nucleic acid amplification test. The intent was to provide a more timely result and decrease unnecessary drug exposure to the patient.
Implementation of In-house PCR Testing for Herpes Simplex Virus
Methods. We conducted a retrospective chart review of adult patients (>18 yo) admitted between June-September 2015 and June-September 2016 who underwent CSF testing for HSV and received empiric acyclovir. The aim was to determine whether the newly available test resulted in fewer doses of acyclovir in those who tested negative for a herpes virus as compared with those tested with the previously available assay. We excluded those found to be positive for HSV-1, HSV-2, or VZV in the CSF. We defined a dose as any administration of acyclovir or valacyclovir to the patient.
Results. Results of the diagnostic assay returned significantly faster after institution of the ME panel (4.9 days (118 hours) vs .09 days (2.25 hours)). Due to the non-normal distribution of acyclovir dosing, comparisons were made with the Wilcoxson Rank-sum. The institution of the ME panel for all CSF studies significantly impacted our use of acyclovir, as patients with negative tests for HSV PCR in the CSF received fewer doses of acyclovir after implementation of the ME panel (median (25   th   -75 th percentiles) 6 (2-13.5) vs 3 (1-6), P = .018). Conclusion. Implementation of a rapid diagnostic PCR based test for HSV 1 and HSV 2 in 2016 significantly reduced the number of empiric acyclovir doses administered during the summer of 2016 compared with the summer of 2015 in patients testing negative for the condition. Friday, October 6, 2017: 12:30 PM Background. Naegleria fowleri is a climate-sensitive thermophilic ameba found in freshwater that causes primary amebic meningoencephalitis (PAM; 0-8 infections per year in the U.S.) when it enters the nose and migrates to the brain. Patient exposure to water containing the ameba typically occurs in warm freshwater lakes and ponds during recreational water activities. In June 2016, an 18-year-old woman died of PAM after traveling to North Carolina, where she participated in whitewater rafting on an artificial whitewater river.
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A Primary Amebic Meningoencephalitis Case Associated with Rafting on an
Methods. To determine water exposures, we reviewed medical records and conducted interviews with family and individuals who had traveled with the case-patient. To further investigate the artificial whitewater river as a possible exposure source, we visited the whitewater facility and collected water, biofilm, and sediment samples from the facility and from the nearby natural river. We performed select water quality tests onsite and tested for the presence of N. fowleri by culture and real-time PCR in the laboratory.
Results. Interviews revealed that the case-patient's most probable water exposure in the 10 days before becoming ill occurred while rafting on an artificial whitewater river during which she was thrown out of the raft and submerged underwater. The ~11.5 million gallons of water in the whitewater facility were filtered, subjected to UV light, and occasionally chlorinated. Heavy algal growth was noted. The free chlorine residual was 0.05 mg/L, turbidity was 6.7 NTU, and water temperature was 30°C in
